• Users Online: 454
  • Home
  • Print this page
  • Email this page
Home About us Editorial board Search Ahead of print Current issue Archives Submit article Instructions Subscribe Contacts Login 
This article has been cited by
1Phase I study of samalizumab in chronic lymphocytic leukemia and multiple myeloma: blockade of the immune checkpoint CD200
Daruka Mahadevan,Mark C. Lanasa,Charles Farber,Manjari Pandey,Maria Whelden,Susan J. Faas,Terrie Ulery,Anjli Kukreja,Lan Li,Camille L. Bedrosian,Xiaoping Zhang,Leonard T. Heffner
Journal for ImmunoTherapy of Cancer.2019;7(1)
[DOI]

Subscribe this journal
Submit articles
Most popular articles
Joiu us as a reviewer
Email alerts
Recommend this journal